Literature DB >> 2557847

Apparent inactivation of alpha 1-antiproteinase by sulphur-containing radicals derived from penicillamine.

O I Aruoma1, B Halliwell, J Butler, B M Hoey.   

Abstract

alpha 1-Antiproteinase is the major inhibitor of proteolytic enzymes, such as elastase, in human plasma. Its elastase-inhibitory capacity can be inactivated by exposure to hydroxyl radicals (.OH) generated either by pulse radiolysis or by an Fe3+-EDTA/H2O2/ascorbic acid system. Inactivation of alpha 1-antiproteinase by radiolytically-generated .OH under anoxic conditions was decreased by adding a range of anti-inflammatory drugs to the reaction mixtures, including the thiol compound penicillamine. However, under conditions favouring formation of oxysulphur radicals, protection by thiols such as penicillamine was much decreased. It is proposed that sulphur-containing radicals resulting from attack of biologically-produced oxidants upon penicillamine in the presence of O2 can themselves inactivate alpha 1-antiproteinase, and that such radicals might contribute to the side-effects produced by penicillamine or gold thiol therapy in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557847     DOI: 10.1016/0006-2952(89)90642-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Drug derived radicals: mediators of the side effects of anti-inflammatory drugs?

Authors:  B Halliwell; P J Evans; H Kaur; S Chirico
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid.

Authors:  H Kaur; S E Edmonds; D R Blake; B Halliwell
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

3.  Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of alpha1-antiproteinase by mercaptoethylguanidine.

Authors:  M Whiteman; C Szabó; B Halliwell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 4.  Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.

Authors:  Shivangi Patel; Hasnat Khan; Anuradha Majumdar
Journal:  Metab Brain Dis       Date:  2022-05-26       Impact factor: 3.655

Review 5.  Drug antioxidant effects. A basis for drug selection?

Authors:  B Halliwell
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.